Central serous chorioretinopathy associated with administration of sympathomimetic agents

John C. Michael; John Pak; Jose Pulido; Guillermo De Venecia

doi:10.1016/S0002-9394(03)00076-X

Central serous chorioretinopathy associated with administration of sympathomimetic agents

John C. Michael, John Pak, Jose Pulido, Guillermo De Venecia

Ophthalmology

Research output: Contribution to journal › Article › peer-review

53 Scopus citations

Abstract

PURPOSE: To report central serous chorioretinopathy associated with excessive use of compounds with sympathomimetic activity. DESIGN: Observational case series. METHODS: Four patients presented with clinical and fluorescein angiographic evidence of central serous chorioretinopathy. All patients expressed a concomitant psychogenic stress and high-dose ingestion of pseudoephedrine, oxymetazoline, or 3,4-methylenedioxymethamphetamine, all of which possess sympathomimetic properties. RESULTS: In all cases, resolution of central serous chorioretinopathy coincided with cessation of the medication. CONCLUSIONS: Patients afflicted with central serous chorioretinopathy should be notified about its possible association with sympathomimetic medications.

Original language	English (US)
Pages (from-to)	182-185
Number of pages	4
Journal	American journal of ophthalmology
Volume	136
Issue number	1
DOIs	https://doi.org/10.1016/S0002-9394(03)00076-X
State	Published - Jul 1 2003

ASJC Scopus subject areas

Ophthalmology

Access to Document

10.1016/S0002-9394(03)00076-X

Fingerprint Dive into the research topics of 'Central serous chorioretinopathy associated with administration of sympathomimetic agents'. Together they form a unique fingerprint.

Cite this

@article{353fea0761044bffa1a9d2d6887dec98,

title = "Central serous chorioretinopathy associated with administration of sympathomimetic agents",

abstract = "PURPOSE: To report central serous chorioretinopathy associated with excessive use of compounds with sympathomimetic activity. DESIGN: Observational case series. METHODS: Four patients presented with clinical and fluorescein angiographic evidence of central serous chorioretinopathy. All patients expressed a concomitant psychogenic stress and high-dose ingestion of pseudoephedrine, oxymetazoline, or 3,4-methylenedioxymethamphetamine, all of which possess sympathomimetic properties. RESULTS: In all cases, resolution of central serous chorioretinopathy coincided with cessation of the medication. CONCLUSIONS: Patients afflicted with central serous chorioretinopathy should be notified about its possible association with sympathomimetic medications.",

author = "Michael, {John C.} and John Pak and Jose Pulido and {De Venecia}, Guillermo",

year = "2003",

month = jul,

day = "1",

doi = "10.1016/S0002-9394(03)00076-X",

language = "English (US)",

volume = "136",

pages = "182--185",

journal = "American Journal of Ophthalmology",

issn = "0002-9394",

publisher = "Elsevier USA",

number = "1",

}

TY - JOUR

T1 - Central serous chorioretinopathy associated with administration of sympathomimetic agents

AU - Michael, John C.

AU - Pak, John

AU - Pulido, Jose

AU - De Venecia, Guillermo

PY - 2003/7/1

Y1 - 2003/7/1

N2 - PURPOSE: To report central serous chorioretinopathy associated with excessive use of compounds with sympathomimetic activity. DESIGN: Observational case series. METHODS: Four patients presented with clinical and fluorescein angiographic evidence of central serous chorioretinopathy. All patients expressed a concomitant psychogenic stress and high-dose ingestion of pseudoephedrine, oxymetazoline, or 3,4-methylenedioxymethamphetamine, all of which possess sympathomimetic properties. RESULTS: In all cases, resolution of central serous chorioretinopathy coincided with cessation of the medication. CONCLUSIONS: Patients afflicted with central serous chorioretinopathy should be notified about its possible association with sympathomimetic medications.

AB - PURPOSE: To report central serous chorioretinopathy associated with excessive use of compounds with sympathomimetic activity. DESIGN: Observational case series. METHODS: Four patients presented with clinical and fluorescein angiographic evidence of central serous chorioretinopathy. All patients expressed a concomitant psychogenic stress and high-dose ingestion of pseudoephedrine, oxymetazoline, or 3,4-methylenedioxymethamphetamine, all of which possess sympathomimetic properties. RESULTS: In all cases, resolution of central serous chorioretinopathy coincided with cessation of the medication. CONCLUSIONS: Patients afflicted with central serous chorioretinopathy should be notified about its possible association with sympathomimetic medications.

UR - http://www.scopus.com/inward/record.url?scp=0038692189&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038692189&partnerID=8YFLogxK

U2 - 10.1016/S0002-9394(03)00076-X

DO - 10.1016/S0002-9394(03)00076-X

M3 - Article

C2 - 12834690

AN - SCOPUS:0038692189

VL - 136

SP - 182

EP - 185

JO - American Journal of Ophthalmology

JF - American Journal of Ophthalmology

SN - 0002-9394

IS - 1

ER -